Virtus LifeSci Biotech Products ETF (BBP US) stock market data APIs
108.8104
0.11(0.1%)
as of September 3, 2026
Try our APIs with
free plan!
Virtus LifeSci Biotech Products ETF Financial Data Overview
Price chart is built with
Anychart
Prev. Close
108.8104
Open
108.9228
High
108.931
Low
108.6988
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Virtus LifeSci Biotech Products ETF data using free add-ons & libraries
End-of-day & Earnings data
Get Virtus LifeSci Biotech Products ETF Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get Virtus LifeSci Biotech Products ETF End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Virtus LifeSci Biotech Products ETF News
New
Bet on These Biotech ETFs as Innovation Drives Market-Beating Growth
The biotechnology industry has been mounting a powerful rally, emerging as a standout performer in the equity market, which has otherwise been dominated by technology giants of late. Over the past yea...
ImmunityBio Lead Bladder Cancer Drug Trial Clears Power Check
ImmunityBio Inc. shares are down during Thursday’s premarket session. Year to date, the stock has jumped over 300%. The company announced that the Independent Data Monitoring Committee (IDMC) confi...
Biotech ETFs Hovering Around a 52-Week: Here's Why
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied 26.1% over the past six months (as of Oct. 27, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 24.4%). Year to da...
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion
SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) shares are trading higher on Monday after the company inked a deal to be acquired by Merck & Company, Inc. (NYSE:MRK) for $47 per share in cash. The acqui...
Get Virtus LifeSci Biotech Products ETF fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
